Renin inhibitor, or inhibitors of renin, are a new group of pharmaceuticals that are used primarily in treatment of hypertension.
They act on the juxtaglomerular cells of kidney, which produce renin in response to decreased blood flow.
Contents |
Examples
See also
References
- ^ Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP (March 2005). "Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients". Circulation 111 (8): 1012–8. doi:. PMID 15723979. http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=15723979.
External links
- Renin inhibitor aliskiren leads to dose-dependent blood pressure reductions - medicalnewstoday.com.
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)




